Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion type Assertion NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_head.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion evidence source_evidence_literature NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion SIO_000772 22617708 NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion wasDerivedFrom befree-20150227 NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion wasGeneratedBy ECO_0000203 NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.